中国研究人员开发微型连续血糖监测系统，与市场领先的系统一样有效

CGM传感器由有机电化学晶体管（OECT）制成，比传统传感器更好地放大信噪比。

A miniature-sized continuous glucose monitoring (CGM) system has been developed by an interdisciplinary team of researchers from various Chinese universities and shown to work as effectively as market-leading systems.

来自中国多所大学的跨学科研究人员团队开发了一种微型连续血糖监测（CGM）系统，该系统与市场领先的系统一样有效。

The CGM sensor is made of an organic electrochemical transistor (OECT), which better amplifies signal-to-noise ratio than conventional sensors. It also features a minimally invasive microneedle array and a viscoelastic and diffusive hydrogel which stabilises the skin-device interface.

CGM传感器由有机电化学晶体管（OECT）制成，比传统传感器更好地放大信噪比。它还具有微创微针阵列和粘弹性扩散水凝胶，可稳定皮肤-设备界面。

In a study published in the peer-reviewed Science Advances journal, the OECT showed comparable sensitivity to the Dexcom G6, which was used as a reference device.

在同行评审的 Science Advances 杂志上发表的一项研究中，OECT 显示出与用作参考设备的 Dexcom G6 相当的灵敏度。

"This fully integrated, wearable device promises enhanced antinoise ability, reliability, and wearability compared to traditional CGMs," claimed Shiming Zhang, study lead and a professor from The University of Hong Kong (HKU).

研究负责人、香港大学 (HKU) 教授张世明表示：“与传统 CGM 相比，这种完全集成的可穿戴设备有望增强抗噪声能力、可靠性和耐磨性。”

OECTs, based on organic mixed ion-electron conductors, "can operate in aqueous environments at low voltage with low power consumption while maintaining stable performance over months," researchers noted. This makes it "ideal" for detecting weak biosignals in living beings, they claimed. Until late, its practical application in wearable CGMs was unexplored.

研究人员指出，基于有机混合离子电子导体的 OECT“可以在低电压、低功耗的水环境中运行，同时保持稳定的性能数月”。他们声称，这使得它成为检测生物体内微弱生物信号的“理想”选择。直到最近，它在可穿戴 CGM 中的实际应用尚未得到探索。

The research team, comprising professors from HKU, Zhejiang University, and Guangzhou Medical University, is now moving forward with the clinical application of their CGM system.

由香港大学、浙江大学和广州医科大学教授组成的研究团队现正推进动态血糖监测系统的临床应用。

In China, SiBionics and Zhejiang POCTech are known developers of globally accepted CGM systems.

在中国，SiBionics 和浙江 POCTech 是全球公认的 CGM 系统的知名开发商。

The world's leading CGM brand, Dexcom, has released the latest iteration of its device, which is progressively being made available across Asia-Pacific. It was recently announced that Dexcom G7 is set to provide direct Bluetooth connectivity to the Apple Watch. The device received the United States Food and Drug Administration clearance two years ago.

全球领先的 CGM 品牌 Dexcom 发布了其最新版本的设备，并正在亚太地区逐步上市。最近宣布 Dexcom G7 将提供与 Apple Watch 的直接蓝牙连接。该设备两年前获得了美国食品和药物管理局的许可。

Meanwhile, the latest innovation in wearable health technology in Singapore, a hydrogel-based sensor, utilises skin biomarkers to potentially monitor diabetes and heart conditions.

与此同时，新加坡可穿戴健康技术的最新创新是一种基于水凝胶的传感器，利用皮肤生物标记物来监测糖尿病和心脏病。